Meros Investment Management, LP Harvard Bioscience Inc Transaction History

Meros Investment Management, LP

$215 Million
Q3 2024

A detailed history of Meros Investment Management, LP transactions in Harvard Bioscience Inc stock. As of the latest transaction made, Meros Investment Management, LP holds 833,589 shares of HBIO stock, worth $1.78 Million. This represents 1.04% of its overall portfolio holdings.

Number of Shares

833,589

Previous 835,213 0.19%

Holding current value

$1.78 Million

Previous $2.38 Million 5.8%

% of portfolio

1.04%

Previous 1.15%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 18, 2024	SELL	$2.64 - $3.54 $4,287 - $5,748	-1,624 Reduced 0.19%	833,589 $2.24 Million
Q2 2024 Aug 15, 2024	BUY	$2.77 - $4.63 $37,176 - $62,139	13,421 Added 1.63%	835,213 $2.38 Million
Q1 2024 May 15, 2024	BUY	$4.02 - $5.39 $8,208 - $11,006	2,042 Added 0.25%	821,792 $3.48 Million
Q4 2023 Feb 14, 2024	BUY	$4.0 - $5.49 $50,532 - $69,355	12,633 Added 1.57%	819,750 $4.39 Million
Q3 2023 Nov 14, 2023	SELL	$4.0 - $5.82 $23,588 - $34,320	-5,897 Reduced 0.73%	807,117 $3.47 Million
Q2 2023 Aug 11, 2023	SELL	$4.19 - $6.16 $1.3 Million - $1.92 Million	-311,192 Reduced 27.68%	813,014 $4.46 Million
Q1 2023 May 16, 2023	SELL	$2.45 - $4.22 $30,965 - $53,336	-12,639 Reduced 1.11%	1,124,206 $4.72 Million
Q4 2022 Feb 14, 2023	BUY	$2.12 - $2.86 $848,871 - $1.15 Million	400,411 Added 54.37%	1,136,845 $3.15 Million
Q3 2022 Nov 14, 2022	BUY	$2.33 - $3.92 $266,675 - $448,655	114,453 Added 18.4%	736,434 $1.89 Million
Q2 2022 Aug 12, 2022	BUY	$3.28 - $6.42 $316,175 - $618,855	96,395 Added 18.34%	621,981 $2.24 Million
Q1 2022 May 13, 2022	BUY	$5.16 - $7.14 $480,607 - $665,026	93,141 Added 21.54%	525,586 $3.26 Million
Q4 2021 Feb 16, 2022	BUY	$6.37 - $8.18 $2.75 Million - $3.54 Million	432,445 New	432,445 $3.05 Million

Others Institutions Holding HBIO

# of Institutions

Shares Held

30.6M

Call Options Held

700

Put Options Held

2.1K

View Full List

About HARVARD BIOSCIENCE INC

Ticker HBIO
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 41,636,500
Market Cap $89.1M
Description
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...

More about HBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Meros Investment Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Meros Investment Management, LP with notifications on news.

Account

Meros Investment Management, LP Harvard Bioscience Inc Transaction History